Harbin Pharm Group Sanjing Pharmaceutical Co Ltd, one of China's leading pharmaceutical manufacturers, announced Sunday that its net profit in the third quarter rose 12.49 percent year-on-year to 80.1 million yuan ($11.7 million).
Total assets of the northeastern Heilongjiang-based firm increased 9.3 percent year-on-year to 3.19 billion yuan, it said in a statement to the Shanghai Stock Exchange.
The company attributed the net profit rise to its sound business operating situation and reduced inventory.
The equities of the Shanghai-listed firm ended at 17.71 yuan per share on Friday, up 1.78 percent from the previous close.
